Quantcast

Latest Vaccinogen Inc. Stories

2014-08-25 08:27:12

Initial Closing is for $10 Million FREDERICK, Md., Aug. 25, 2014 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer immunotherapy development company, announced today that it completed the initial closing of a private placement of $80 million of units and common stock. Vaccinogen received gross proceeds of $10 million in this first closing. http://photos.prnewswire.com/prnvar/20140825/139089 Vaccinogen is preparing to start ACTIVE, a confirmatory Phase IIIb pivotal...

2010-11-09 10:22:00

FREDERICK, Md., Nov. 9, 2010 /PRNewswire/ -- Vaccinogen BV, a wholly-owned subsidiary of Vaccinogen, Inc. has been granted a Hospital Exemption by the Dutch Ministry of Health, Welfare and Sport for its colon cancer vaccine, OncoVAX®. Hospital Exemption is based on EU and Member State regulations and can be granted for qualified Advanced Therapeutic Medicinal Products ("ATMP") to ease their availability to medical practitioners and individual patients. To grant a hospital...

2010-09-30 10:12:00

FREDERICK, Md., Sept. 30 /PRNewswire/ -- Vaccinogen, Inc. has appointed veteran biotechnology executive Michael L. Kranda as President and Chief Executive Officer to guide it through its next stage of growth. "The timing couldn't be better - as the company proceeds to finance and launch our pivotal Phase III clinical trial," said Michael G. Hanna, Jr., Ph.D., Vaccinogen's Founder & Chairman and inventor of the company's unique cancer-fighting vaccine OncoVAX®....


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related